FUSE MEDICAL, INC. (OTCMKTS:FZMD) Files An 8-K Completion of Acquisition or Disposition of Assets

FUSE MEDICAL, INC. (OTCMKTS:FZMD) Files An 8-K Completion of Acquisition or Disposition of Assets
Item 9.01

Story continues below

Completion of Acquisition or Disposition of Assets.

On December 29, 2017, Fuse Medical, Inc. (the “Company”) completed the previously-announced acquisition of CPM Medical Consultants, LLC (the “Target”), to that certain Purchase Agreement (the “Purchase Agreement”), by and between the Company and NC 143 Family Holdings, LP (“NC 143”), dated December 15, 2017, whereby the Company would purchase all of the outstanding membership interests of the Target, as disclosed in the Company’s Form 8-K filed on December 19, 2017. The Company issued 50,000,000 shares of its common stock, par value $0.01 per share (“Common Stock”) in exchange for 50% of the outstanding equity interests of the Target, at an agreed-upon value of $0.20 per share of Common Stock, as reflected in the fairness opinion provided by ValueScope, Inc. and filed as Exhibit 99.1 to the Company’s Current Report on Form 8-K, filed with the Commission on December 19, 2017. The effective date of the closing was December 31, 2017.

Item 9.01.

Regulation FD Disclosure.

On January 5, 2018, the Company issued a press release, attached hereto as Exhibit 99.2, announcing the Company’s completion of the acquisition of the Target to the Purchase Agreement.

Item 9.01.

Financial Statements and Exhibits.

(b)

Pro forma financial information.

The pro forma financial information required to be furnished under this Item 9.01(b) is furnished as Exhibit 99.1 to this Current Report on 8-K and is incorporated herein by reference.

(d)

Exhibits


Fuse Medical, Inc. Exhibit
EX-99.1 2 fzmd-ex991_71.htm EX-99.1 fzmd-ex991_71.htm EXHIBIT 99.1 FUSE MEDICAL,…
To view the full exhibit click here

About FUSE MEDICAL, INC. (OTCMKTS:FZMD)

Fuse Medical, Inc., formerly Golf Rounds.com, Inc., is engaged in marketing, distributing and selling internal fixation, bone materials, biologics, tissues, surgical and other related surgical products. The Company operates through medical products and supplies segment. The Company’s products consist of plates and screws for recurring bone fractures, allografts for bone chips and tendons, and amniotics. Its products are used in a range of surgical procedures in various types of facilities (ambulatory surgical centers, hospitals and physician offices, and other medical facilities) where surgeons and doctors treat patients and operate. It markets, distributes and sells a range of existing Food and Drug Administration-approved and state licensed products and services manufactured or produced by other organizations where it is considered as a distributor and a stocking distributor. Its customers are physicians, orthopedic surgeons, hospitals, surgical facilities and physician practices.

An ad to help with our costs